Am J Transplant, Volume 21, Suppl 3 Archives - Page 105 of 139 - ATC Abstracts

2021 American Transplant Congress
Living Donor Liver Transplant for Unresectable Colorectal Metastasis: A Case Series
B. Emmanuel, H. Al-Harakeh, A. Humar, C. Hughes, A. Tevar, M. Molinari, A. Ganoza
Starzl Transplant Institute, UPMC, Pittsburgh, PA
*Purpose: Colorectal Cancer (CRC) represents the third most common malignancy worldwide. In the US, CRC lifetime risk is approximately 1 in 23 (4.4%) for men…
2021 American Transplant Congress
Peripheral Blood Inflammatory Chemokines Uncover Rejection in the Absence of Histological Lesions
E. Van Loon¹, T. Barba², B. Lamarthée¹, A. Senev¹, O. Thaunat², D. Schols³, M. Naesens¹
¹Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium, ²Department of Transplantation, Nephrology and Clinical Immunology, Edouard Herriot Hospital Lyon, Lyon, France, ³Laboratory of Virology and Chemotherapy, KU Leuven, Leuven, Belgium
*Purpose: Cytokines and chemokines play a critical role in the pathophysiology of allograft rejection, but the relation of peripheral blood cytokine expression profiles to clinical…
2021 American Transplant Congress
Simultaneous Pancreas-Kidney Transplantation in Caucasian versus African American Patients: Does Recipient Ethnicity Influence Outcomes?
J. Rogers¹, A. Farney², G. Orlando², C. Jay², K. Gurung², B. Sharda², A. Reeves-Daniel³, A. Mena-Gutierrez³, N. Sakhovskaya³, W. Doares⁴, S. Kaczmorski⁴, M. Magid⁴, M. Gautreaux², R. Stratta²
¹Wake Forest Baptist Medical Center, Winston-Salem, NC, ²Department of Surgery, Wake Forest Baptist Medical Center, Winston-Salem, NC, ³Internal Medicine, Wake Forest Baptist Medical Center, Winston-Salem, NC, ⁴Department of Pharmacy, Wake Forest Baptist Medical Center, Winston-Salem, NC
*Purpose: The influence of African American (AA) recipient ethnicity on outcomes following simultaneous pancreas-kidney transplantation (SPKT) in the modern era is uncertain.*Methods: From 11/01 to…
2021 American Transplant Congress
The Effect of the Affordable Care Act on Insurance Status, Waitlist, and Transplant Outcomes in Liver Transplantation
B. I. Shaw¹, M. L. Samoylova¹, V. Wang², T. Risoli Jr³, S. Peskoe³, K. Caddell³, L. M. McElroy¹
¹Surgery, Duke University, Durham, NC, ²Population Health Sciences, Duke University, Durham, NC, ³Biostatistics, Duke University, Durham, NC
*Purpose: The Affordable Care Act (ACA) intended to expand Medicaid to cover all adults with income below 138% of federal poverty level. We describe the…
2021 American Transplant Congress
Successful Outcomes from Selected Akin3 Donors Requiring Renal Replacement: Avenue for Increase in Organ Utilization
P. Budhiraja¹, R. L. Heilman¹, M. L. Smith², H. A. Khamash¹, L. Kodali¹, A. A. Moss³, A. K. Mathur³, C. Jadlowiec³, K. S. Reddy³
¹Medicine, Mayo Clinic, Phoenix, AZ, ²Pathology, Mayo Clinic, Phoenix, AZ, ³Surgery, Mayo Clinic, Phoenix, AZ
*Purpose: Our aim was to determine outcomes with transplanting kidneys from deceased donors with severe acute kidney injury requiring acute renal replacement therapy.*Methods: We included…
2021 American Transplant Congress
Impact of Statin Intensity on the Incidence of Vascular Events and Graft Survival in Heart Transplant Recipients
E. Kim¹, I. Booth², R. Madathil³, B. Ravichandran¹, M. Demehin², M. Plazak²
¹University of Maryland School of Pharmacy, Baltimore, MD, ²Pharmacy, University of Maryland Medical Center, Baltimore, MD, ³University of Maryland School of Medicine, Baltimore, MD
*Purpose: Cardiac allograft vasculopathy (CAV) limits long-term graft survival of heart transplant (HT) recipients. In addition to decreased synthesis of cholesterol, statins also demonstrate immunomodulatory…
2021 American Transplant Congress
Optimal Antimicrobial Duration for Donor Positive Cultures in Kidney Transplant Recipients
J. Ferrante, K. Schnelle, M. Palettas, S. Sarwar, H. Winters, M. Chunduru
Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH
*Purpose: Utilization of organs from infected donors carries the risk of transmission of the donor organism to the recipient. While antimicrobials are recommended in recipients…
2021 American Transplant Congress
Worsening Impact of Acute Kidney Rejection on Long Term Graft Survival from 2000 to 2014
D. Leeser¹, W. Irish¹, K. Ravindra², V. Villani², A. Connor², J. Tuttle¹
¹Surgery, East Carolina University, Greenville, NC, ²Surgery, Duke University, Durham, NC
*Purpose: Acute rejection (AR) has been shown to impact graft survival after kidney transplant (KTx), however there is limited data on its impact on long…
2021 American Transplant Congress
Impact Analysis of Virtual Transplant Ambulatory Pharmacist During Covid-19
L. Park, G. Waldman, J. Kim, C. Rogers, J. Clark
Massachusetts General Hospital, Boston, MA
*Purpose: During the COVID-19 pandemic, transplant centers were challenged to meet the demand for new telemedicine strategies. High-risk immunocompromised patients, such as lung transplant recipients…
2021 American Transplant Congress
Response to a Pandemic: The Fall and Rise of Kidney Transplantation in the US
S. Bisen¹, B. Boyarsky¹, W. Werbel¹, J. Snyder², J. Garonzik-Wang¹, D. Segev¹, A. Massie¹
¹JHU, Baltimore, MD, ²SRTR, Minneapolis, MN
*Purpose: During the first wave of the COVID-19 epidemic in March-April 2020, waitlist registrations and living/deceased donor kidney transplants (LDKT/DDKT) dropped substantially. A second wave…